Siemens Energy CEO, Dr Christian Bruch on the energy transition

As a global leader in wind turbines, utility scale gas turbines and grid transmission equipment, Siemens Energy is at the forefront of the transition to net zero and provides investors one of the most well-rounded decarbonisation exposures.

In this podcast episode, Alison Savas is joined by Siemens Energy CEO, Dr Christian Bruch.

Dr Bruch shares unique perspectives into the challenges the world faces in the energy transition. Some of the numbers he discusses are so large it’s hard to get your head around them. For example, Dr Bruch explains that the annual installation of offshore wind turbines needs to increase by 7-8x to meet 2030 targets.

Similarly, the annual investment in the grid in the EU needs to at least double by 2030 as the grid needs to be rebuilt and extended to distribute renewables.

Dr Bruch also provides insight into how Siemens Energy is positioned within this generational investment cycle and how the business can deliver meaningful top line growth and a substantial profit swing over the coming years.   

Key times:

  • The net zero ‘trilemma’ & are the targets achievable? – 02:40
  • The critical role of wind energy – 06:00
  • Bottlenecks in delivering sufficient offshore wind infrastructure – 12:10
  • Profitability of wind projects – 18:20
  • The role of gas in decarbonisation – 27:30
  • The enormity of the energy grid investment required to facilitate net zero targets – 31:00





*Individual stock commentary is illustrative only and not a recommendation to buy, hold, or sell any security. 

You can subscribe to our podcast on AppleGoogle or Spotify, to be notified as soon as upcoming episodes are published

Subscribe to receive the latest news and insights from the Antipodes team

Subscribe to updates

All content in respect of the Antipodes Global Shares (Quoted Managed Fund) (ARSN 625 560 269), the Antipodes Global Fund – Long (ARSN 118 075 764), the Antipodes Global Fund (ARSN 087 719 515), and the Antipodes Emerging Markets (Managed Fund) (ARSN 096 451 393) is issued by Pinnacle Fund Services Limited ABN 29 082 494 371 AFSL 238 371 (“PFSL”) as responsible entity of the Funds and is prepared by Antipodes Partners Limited (ABN 29 602 042 035) (AFSL 481580) (“Antipodes”) as the investment manager of the Trust. PFSL is not licensed to provide financial product advice.
The information provided is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Funds, you should consider the current Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the Funds and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser. The Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the relevant Fund are available via below links. Any potential investor should consider the PDS and TMD before deciding whether to acquire, or continue to hold units in, the Fund.
Links to Product Disclosure Statement: IOF0045AU, WHT0057AU, IOF0203AUWHT3997AU
Links to Target Market Determination: IOF0045AU, WHT0057AU, IOF0203AUWHT3997AU
For historic TMD’s please contact Pinnacle client service Phone 1300 010 311 or Email
Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Funds. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this content. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance.

8 March 2023